Contracts expiring soon — NAICS 541714 · Research and Development in Biotechnology (except Nanobiotechnology)

When a federal contract hits its end date, the agency usually buys the same thing again — and the rebid is open to anyone. These are the Research and Development in Biotechnology (except Nanobiotechnology) contracts coming up for renewal, soonest first.

529 contracts on the radar — page 10 of 11
THE OVERALL OBJECTIVE OF THIS CONTRACT IS TO PROVE A METHODOLOGY TO MEASURE DOSE IN A PHANTOM SUCH THAT THERE WILL BE RESULT NIST TRACEABLE DOSE HARMONIZATION AMONG INSTITUTIONS. INCLUDED IN THIS ACTIVITY WILL BE A MEASURE OF THE RADIATION FIELD USIN
UNIVERSITY OF WISCONSIN SYSTEM · Department of Health and Human Services · WI
expires Sep 30, 2027 · $449,084
THE DEVELOPMENT OF A MULTIMODAL ANTIBODY PLATFORM TO EXTEND THE WINDOW OF IMMUNOTHERAPEUTIC INTERVENTION. THE OVERALL OBJECTIVE OF THE WORK OUTLINED IN THIS CONTRACT IS TO CRITICALLY EVALUATE THE UTILITY OF THE VHH AS A PLATFORM MCM TECHNOLOGY FOR VI
EITR BIOLOGICS, INC. · Department of Health and Human Services · CA
expires Sep 30, 2027 · $33,059,642
DESIGN, DEVELOPMENT, AND TESTING OF GROUND AND FLIGHT UNIT(S) AS WELL AS COMPLETION OF FLIGHT DEMONSTRATION(S) ON THE ISS NATIONAL LAB (NL) OR A CLD OR OTHER LEO ORBITAL PLATFORM.
NATIONAL STEM CELL FOUNDATION INC. · National Aeronautics and Space Administration · KY
expires Sep 30, 2027 · $5,294,059
LABORATORY ASSAY FOR TRAUMATIC BRAIN INJURY
ABBOTT LABORATORIES INC. · Department of Defense · IL
expires Sep 30, 2027 · $37,604,629
REPURPOSING OF A FERRIC IRON-CONTAINING HEME B COMPLEX (PANHEMATIN) AND A SULFANE SULFUR-LINKED DITHIOCARBAMATE (DISULFIRAM) AS POTENTIAL MCMS AGAINST KNOCKDOWN AGENTS
BATTELLE MEMORIAL INSTITUTE · Department of Health and Human Services · OH
expires Sep 30, 2027 · $8,384,176
PREFLIGHT PROJECT GOAL IS TO PROVIDE THE REQUIRED PREFLIGHT TESTS TO SUPPORT THE AVATAR FLIGHT PROJECT FOR ITS ARTEMIS II MISSION.
PRESIDENT AND FELLOWS OF HARVARD COLLEGE · Department of Health and Human Services · MA
expires Sep 30, 2027 · $3,196,979
DR. WEINER STUDY OF CONTEXTUAL ERRORS IN MEDICAL DECISION MAKING WITH THE UNIVERSITY OF ILLINOIS - CHICAGO
UNIVERSITY OF ILLINOIS · Department of Veterans Affairs · IL
expires Sep 30, 2027 · $673,990
INTEGRASE INHIBITOR LAT FLOW DEVICES - EO 14398
BEACON SCIENTIFIC INC · Department of Health and Human Services · CA
expires Oct 20, 2027 · $234,000
SERVICES TO COLLECT NEXT-GENERATION SEQUENCING DATA FOR GENOME SKIMMING, POPULATION STRUCTURE, AND RELATED GENOMIC DATA NEEDS IN MANAGEMENT-RELEVANT MARINE SPECIES.
SEQMATIC, LLC · Department of Commerce · CA
expires Oct 21, 2027 · $16,860 · SMALL BUSINESS SET ASIDE - TOTAL
RESEARCH AND DEVELOPMENT
SOLVUS GLOBAL LLC · Department of Defense · MA
expires Oct 29, 2027 · $999,914 · SMALL BUSINESS SET ASIDE - TOTAL
RADNUC 2201: PERFORMANCE VERIFICATION OF INSTITUTIONAL RADIATION DOSE RESPONSE FOR ACUTE RADIATION SYNDROME (ARS) ANIMAL MODELS (RODENT, RABBIT, MINIPIG, OR NON-HUMAN PRIMATE [NHP]).
UNIVERSITY OF MARYLAND, BALTIMORE · Department of Health and Human Services · MD
expires Nov 28, 2027 · $8,423,324
PHASE II SBIR ROBUST OPERATIONAL ULTRA-HIGH THROUGHPUT CELL LINEAGE TRACKING FOR RAPID BIOENGINEERING AND PATHOGEN DETECTION
BIFROST BIOSYSTEMS INC · Department of Defense · CA
expires Nov 30, 2027 · $2,968,910 · SMALL BUSINESS SET ASIDE - TOTAL
THIS IS A NEW PURCHASE ORDER FOR INTERNATIONAL COMMITTEE FOR INFORMATION TECHNOLOGY STANDARDS (INCITS) MEMBERSHIP.
INFORMATION TECHNOLOGY INDUSTRY COUNCIL INC · Department of Homeland Security · DC
expires Nov 30, 2027 · $9,100
LUNGPACER MEDICAL USA INC LUNG-PROTECTIVE EFFECTS OF TRANSVENOUS DIAPHRAGM ACTIVATION IN PATIENTS WITH ARDS AOI #12: MITIGATING LONG-TERM EFFECTS (MILE) OF RESPIRATORY DISTRESS
LUNGPACER MEDICAL USA INC · Department of Health and Human Services · PA
expires Dec 15, 2027 · $749,796
CHEM 2207- EVALUATION OF LYOPHILIZED ELAPID VENOM ACETYLCHOLINESTERASE AND GLYCOPYRROLATE VERSUS CRITERION STANDARD TREATMENT ON NERVE AGENT MORTALITY (ELEVATE CST STUDY)
BATTELLE MEMORIAL INSTITUTE · Department of Health and Human Services · OH
expires Dec 15, 2027 · $1,007,299
THE OVERALL OBJECTIVE OF THIS CONTRACT IS TO ADVANCE THE DEVELOPMENT OF THE BIOFIRE EMERGING COV PANEL AS A NUCLEIC ACID AMPLIFICATION TEST PANEL FOR USE ON THE EASY-TO-USE FILMARRAY 2.0 AND FILMARRAY TORCH PLATFORMS.
BIOFIRE DEFENSE LLC · Department of Health and Human Services · UT
expires Dec 22, 2027 · $15,958,896
THE OVERARCHING OBJECTIVE IS TO ESTABLISH A QUANTITATIVE IN VITRO IN VIVO EXTRAPOLATION FRAMEWORK CAPABLE OF PREDICTING THE INFLUENCE OF FORMULATION COMPOSITION, DIGESTION BEHAVIOR, CHYLOMICRON BINDING, AND PRANDIAL STATE ON DRUG BIOAVAILABILITY AND
SIMULATIONS PLUS INC · Department of Health and Human Services · MD
expires Dec 29, 2027 · $651,399
EO 14398-BROAD AGENCY ANNOUNCEMENT (BAA) CONTRACT FOR MODERNIZING OUTCOME DATA FOR OPIOID USE DISORDER (MOD-OUD)
DIGITAL MEDICINE SOCIETY INC · Department of Health and Human Services · MA
expires Dec 30, 2027 · $948,781
FEASIBILITY STUDY OF FLYING ORGANOIDS IN LEO USING THE SAME PAYLOAD MODEL AS FLOWN ON ARTEMIS II.
STI LEGACY, INC. · National Aeronautics and Space Administration · KY
expires Dec 30, 2027 · $2,831,047
THIS CONTRACT IS TO ADVANCE THE DEVELOPMENT OF ROMIPLOSTIM FOR TREATMENT OF HEMATOPOIETIC SUBSYNDROME-ACUTE RADIATION SYNDROME (HS-ARS) AND CHEMOTHERAPY-INDUCED THROMBOCYTOPENIA (CIT) AND A DRUG DELIVERY DEVICE FEASIBILITY PROJECT WITH AN OPTION TO
AMGEN INC. · Department of Health and Human Services · CA
expires Dec 31, 2027 · $26,408,674
ACE RAPID MOLECULAR TEST SYSTEM FOR POINT OF CARE (POC) AND IN-HOME USE WITH SALIVA AND SWAB SAMPLES FOR COVID-19 AND BEYOND
APTITUDE MEDICAL SYSTEMS INC · Department of Health and Human Services · MD
expires Dec 31, 2027 · $38,271,970
NICHD: SERVICE: CCTN LB PHASE 2B CLINICAL TRIAL: NON-SEVERABLE
OLD DOMINION UNIVERSITY · Department of Health and Human Services · VA
expires Dec 31, 2027 · $508,827
NICHD: R&D: TO EVALUATE IN OBESE AND NON-OBESE WOMEN THE PHARMACOKINETICS (PK), PHARMACODYNAMIC (PD) EFFECTS, SAFETY, AND CONTRACEPTIVE EFFICACY OF LEVONORGESTREL BUTANOATE (LB) FORMULATED AS A LONG-ACTING INJECTABLE: NON-SEVERABLE
OREGON HEALTH & SCIENCE UNIVERSITY · Department of Health and Human Services · OR
expires Dec 31, 2027 · $543,457
OT TASK ORDER 5
ADVANCED TECHNOLOGY INTERNATIONAL · Department of Health and Human Services · SC
expires Dec 31, 2027 · $161,082,263
NICHD: SERVICE: CCTN LB PHASE 2B CLINICAL TRIAL: NON-SEVERABLE
THE REGENTS OF THE UNIVERSITY OF COLORADO · Department of Health and Human Services · CO
expires Dec 31, 2027 · $585,325
ADIPOSE TISSUE MECHANOSENSING IN TRUE MICROGRAVITY (PDR THROUGH FLIGHT)
REDWIRE SPACE TECHNOLOGIES, INC. · National Aeronautics and Space Administration · IN
expires Dec 31, 2027 · $396,881
RESEARCH AND DEVELOPMENT
ATMO, INC. · Department of Defense · CA
expires Dec 31, 2027 · $987,006 · SMALL BUSINESS SET ASIDE - TOTAL
NICHD:R&D:CENTRAL LABORATORY FOR A PHASE 2B STUDY TO EVALUATE THE EFFICACY AND SAFETY OF SUBCUTANEOUS LEVONORGESTREL BUTANOATE FOR FEMALE CONTRACEPTION:NON-SEVERABLE
OREGON HEALTH & SCIENCE UNIVERSITY · Department of Health and Human Services · OR
expires Dec 31, 2027 · $720,543
CLINICAL DEVELOPMENT OF OX390 (ATIPAMEZOLE) AS AN ?2 AGONIST REVERSAL AGENT FOR HUMAN USE TO COUNTERACT THE SEDATIVE EFFECTS OF XYLAZINE, MEDETOMIDINE, AND OTHER ?2 AGONISTS
OREXO US INC · Department of Health and Human Services · NJ
expires Dec 31, 2027 · $11,450,712
NICHD: SERVICE: CCTN LB PHASE 2B CLINICAL TRIAL: NON-SEVERABLE
UNIVERSITY OF UTAH · Department of Health and Human Services · UT
expires Dec 31, 2027 · $498,819
NICHD: R&D: A PHASE 2B STUDY TO EVALUATE THE EFFICACY AND SAFETY OF SUBCUTANEOUS LEVONORGESTREL BUTANOATE FOR FEMALE CONTRACEPTION: SEVERABLE
UNIVERSITY OF CALIFORNIA, DAVIS · Department of Health and Human Services · CA
expires Dec 31, 2027 · $532,750
NICHD: R&D: A PHASE 2B STUDY TO EVALUATE THE EFFICACY AND SAFETY OF SUBCUTANEOUS LEVONORGESTREL BUTANOATE FOR FEMALE CONTRACEPTION: NON-SEVERABLE
THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK · Department of Health and Human Services · NY
expires Dec 31, 2027 · $539,573
NOVEL BISPECIFIC BROAD SPECTRUM NANOBODY
EITR BIOLOGICS, INC. · Department of Defense · CA
expires Dec 31, 2027 · $926,999
SWITCH PROGRAM (ICCG) BASE
NATIONAL COLLEGIATE INVENTORS & INNOVATORS ALLIANCE, INC. · Department of Defense · MA
expires Jan 23, 2028 · $999,354
THERAPEUTIC TESTING IN MURINE MODELS OF FUNGAL INFECTIONS
THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO · Department of Health and Human Services · TX
expires Jan 26, 2028 · $386,096
RASP WILL DEVELOP ENHANCED RADAR SP CAPABILITIES THAT TAKE ADVANTAGE OF NEXT GENERATION RECEIVERS/EXCITERS AND COMPUTING ACCELERATORS FOR TRANSITION INTO SHIPBOARD RADARS THAT OPERATE IN INCREASINGLY HARSH ENVIRONMENTS AGAINST CHALLENGING TARGETS
RAYTHEON COMPANY · Department of Defense · MA
expires Jan 31, 2028 · $31,529,402
DEVELOPMENT OF ENZYME-LINKED IMMUNOSORBENT ASSAYS (ELISAS) FOR NINDS NIH BLUEPRINT NEUROTHERAPEUTICS (BPN) BIOLOGICS PROJECT
BATTELLE MEMORIAL INSTITUTE · Department of Health and Human Services · OH
expires Feb 6, 2028 · $531,194
RESEARCH AND DEVELOPMENT FOR IN-SPACE PRODUCTION CONCEPTS OF NANOBIOREACTOR MODELS. THIS WAS AWARDED OFF OF THE NASA RESEARCH ANNOUNCEMENT NNJ13ZBG001N. NOTE THAT "BASIC RESEARCH" IS NOT A SELECTABLE SOLICITATION TYPE FOR PURCHASE ORDERS IN FPDS.
ASPERA BIOMEDICINES, INC. · National Aeronautics and Space Administration · CA
expires Feb 15, 2028 · $12,984,613
BIOLOGICAL TECHNOLOGIES OFFICEWIDE
COUNCIL ON STRATEGIC RISKS (THE) · Department of Defense · DC
expires Feb 20, 2028 · $692,875
TO DEVELOP AND CONDUCT 3D CORRELATIVE IMAGING, QUANTITATIVE AI-BASED ANALYSIS OF CRITICAL QUALITY ATTRIBUTES (CQAS), AND PERFORM IMAGE- BASED IN SILICO RELEASE MODELLING, USING MODEL LONG-ACTING DRUGS, INHALATION PRODUCTS, AND TOPICAL PRODUCTS.
DIGIM SOLUTION LLC · Department of Health and Human Services · MD
expires Feb 28, 2028 · $500,635
RADNUC 2201: PERFORMANCE VERIFICATION OF INSTITUTIONAL RADIATION DOSE RESPONSE FOR ACUTE RADIATION SYNDROME (ARS) ANIMAL MODELS (RODENT, RABBIT, MINIPIG, OR NON-HUMAN PRIMATE [NHP]).
UNIVERSITY OF ILLINOIS · Department of Health and Human Services · IL
expires Feb 28, 2028 · $6,286,605
SUBAGREEMENTS & FLOW-THRU - WRAIR
NATIONAL ACADEMY OF SCIENCES · Department of Defense · MD
expires Feb 29, 2028 · $8,957,844
SUBAGREEMENTS & FLOW-THRU - USAISR
NATIONAL ACADEMY OF SCIENCES · Department of Defense · TX
expires Feb 29, 2028 · $5,777,908
SUBAGREEMENTS & FLOW-THRU - USAMRIID
NATIONAL ACADEMY OF SCIENCES · Department of Defense · MD
expires Feb 29, 2028 · $6,860,925
ADMINISTRATIVE PROGRAM COSTS - USAMRDC
NATIONAL ACADEMY OF SCIENCES · Department of Defense · MD
expires Feb 29, 2028 · $4,017,073
ADVANCE THE DEVELOPMENT OF POTENT, CROSS-REACTIVE MULTISPECIFIC ANTIBODIES FOR THE PREP COUNTERMEASURE OF COVID-19 AND SEASONAL AND HIGHLY PATHOGENIC AVIAN INFLUENZA.
MODEX THERAPEUTICS, INC · Department of Health and Human Services · MA
expires Feb 29, 2028 · $103,516,903
LEVERAGING IKRAPH FOR PERSONALIZED NUTRITION PLANNING IN CANCER PREVENTION AND MANAGEMENT
INSILICOM LLC · Department of the Interior · FL
expires Mar 1, 2028 · $600,000 · SMALL BUSINESS SET ASIDE - TOTAL
LEVERAGING THE GUT MICROBIOME AS AN INTEGRATOR OF NUTRITIONAL STATUS: A FEASIBILITY STUDY OF MICROBIOME NUTRITIONAL DIAGNOSTICS (MINU-DX)
EVIMERO, LLC · Department of the Interior · AL
expires Mar 9, 2028 · $597,482 · SMALL BUSINESS SET ASIDE - TOTAL
BAA BENEFIT-TRANSFER METHODS ON DIABETES MEDICAL DEVICES FY24C1IP2 DPCD
DUKE UNIVERSITY · Department of Health and Human Services · NC
expires Mar 12, 2028 · $699,087
NONCLINICAL SERVICES FOR THE DEVELOPMENT OF INTERVENTIONAL AGENTS FOR INFECTIOUS DISEASES
SRI INTERNATIONAL · Department of Health and Human Services · CA
expires Mar 13, 2028 · $4,950,919
← PrevPage 10 / 11Next →

See your codes' radar every morning.

Subscribers get this same radar filtered to their exact NAICS codes in the daily digest — plus every new open bid that matches. Start your 14-day trial →